Almotriptan is a medication used in the management and treatment of acute migraines. The medication is in the triptan 5-HT class of drugs. Participating clinicians review the indications, actions, and contraindications for almotriptan as a valuable agent in treating and managing acute migraines.This activity highlights the mechanism of action, adverse effects, and vital factors such as dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions pertinent for interprofessional team members in treating and caring for patients with acute migraines and related conditions. The interprofessional team, ranging from primary care clinicians and emergency clinicians to specialists, benefit from guideline-specific practices.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/17383
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Chemical Pathology, General Pediatrics, General Surgery, Geriatric Medicine, Hospice and Palliative Medicine, Hospital Medicine, Internal Medicine, Neuropathology (incl. Neuromuscular), Pain Medicine, Pediatric Neurology, Regional Anesthesia/Acute Pain
Subscribe
Login
0 Comments
Oldest